It has taken a long time for India to develop a productive environment for biotechnology, but Archana Shanker says recent developments appear to have put it on the right track.
The two critical factors conducive to both investment and growth in the biotech sector are government policy on biotechnology and a robust intellectual property protection and enforcement mechanism. The Department of Biotechnology issued a vision statement to provide a broad framework and outline the progress in this sector. Intellectual property, and particularly patents, become the central focus and research development in this area of technology.
As biotech business requires huge front-end investment at a very high risk, an obvious expectation of such investments is to provide market exclusivity with robust judicial enforcement, so as to provide a platform for the high-risk investment to flourish and prosper.
This chapter was published in Life Sciences Intellectual Property Review 2011.
To continue reading, please contact us at email@anandandanand.com
etc. whilst wrongfully claiming to be part of our firm and making false claims and allegations.